Riboflavin 5'-Phosphate
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Keratoconus
Conditions
Keratoconus, Keratoconus, Unstable
Trial Timeline
Jul 18, 2017 → Sep 30, 2019
NCT ID
NCT03245853About Riboflavin 5'-Phosphate
Riboflavin 5'-Phosphate is a approved stage product being developed by Glaukos for Keratoconus. The current trial status is completed. This product is registered under clinical trial identifier NCT03245853. Target conditions include Keratoconus, Keratoconus, Unstable.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03245853 | Approved | Completed |
Competing Products
7 competing products in Keratoconus
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| riboflavin solution + placebo solution | Glaukos | Phase 3 | 74 |
| riboflavin ophthalmic solution | Glaukos | Phase 3 | 74 |
| GLK-221 Ophthalmic Solution + Placebo Ophthalmic Solution | Glaukos | Phase 2 | 49 |
| riboflavin solution + placebo solution | Glaukos | Phase 3 | 74 |
| riboflavin solution + placebo solution | Glaukos | Phase 3 | 74 |
| Test Article A + Test Article B + Placebo | Glaukos | Phase 3 | 74 |
| Dextenza + Prednisolone Acetate | Ocular Therapeutix | Approved | 80 |